Follow
Gareth Parry
Gareth Parry
Emeritus Professor, University of Minnesota, Research Professor, Nelson-Marlborough Institute of Technology
Verified email at nmit.ac.nz
Title
Cited by
Cited by
Year
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
ME Shy, EM Frohman, YT So, JC Arezzo, DR Cornblath, MJ Giuliani, ...
Neurology 60 (6), 898-904, 2003
6782003
A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis
RG Miller, JH Petajan, WW Bryan, C Armon, RJ Barohn, JC Goodpasture, ...
Annals of neurology 39 (2), 256-260, 1996
4201996
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy
JR Mendell, RJ Barohn, ML Freimer, JT Kissel, W King, HN Nagaraja, ...
Neurology 56 (4), 445-449, 2001
3562001
Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease
GJ Parry, S Clarke
Muscle & Nerve: Official Journal of the American Association of …, 1988
3481988
Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial
MI Weintraub, GI Wolfe, RA Barohn, SP Cole, GJ Parry, G Hayat, ...
Archives of physical medicine and rehabilitation 84 (5), 736-746, 2003
3202003
Sensory neuropathy with low‐dose pyridoxine
GJ Parry, DE Bredesen
Neurology 35 (10), 1466-1466, 1985
2691985
Inflammatory neuroprithy in homosexual men with lymphadenopathy
WI Lipkin, G Parry, D Kiprov, D Abrams
Neurology 35 (10), 1479-1479, 1985
2601985
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
RG Miller, DH Moore, DF Gelinas, V Dronsky, M Mendoza, RJ Barohn, ...
Neurology 56 (7), 843-848, 2001
2582001
Electrophysiologic evaluation of lumbosacral radiculopathies: electromyography, late responses, and somatosensory evoked potentials
MJ Aminoff, DS Goodin, GJ Parry, NM Barbaro, PR Weinstein, ...
Neurology 35 (10), 1514-1514, 1985
2441985
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
RR Voskuhl, HJ Wang, TCJ Wu, NL Sicotte, K Nakamura, F Kurth, N Itoh, ...
The Lancet Neurology 15 (1), 35-46, 2016
2102016
Conduction block in clinical practice
DR Cornblath, AJ Sumner, J Daube, RW Gilliat, WF Brown, GJ Parry, ...
Muscle & Nerve: Official Journal of the American Association of …, 1991
1991991
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis
RG Miller, D Moore, LA Young, C Armon, RJ Barohn, MB Bromberg, ...
Neurology 47 (6), 1383-1388, 1996
1851996
Peripheral neuropathies associated with human immunodeficiency virus infection
GJ Parry
Annals of Neurology: Official Journal of the American Neurological …, 1988
1791988
Quantitative sensory testing: effect of site and skin temperature on thermal thresholds
LG Hagander, HA Midani, MA Kuskowski, GJG Parry
Clinical neurophysiology 111 (1), 17-22, 2000
1702000
Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy
CL Koski, M Baumgarten, LS Magder, RJ Barohn, J Goldstein, M Graves, ...
Journal of the neurological sciences 277 (1-2), 1-8, 2009
1652009
Neuropathies associated with excessive exposure to lead
RM Thomson, GJ Parry
Muscle & Nerve: Official Journal of the American Association of …, 2006
1552006
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
KC Gorson, IN Van Schaik, ISJ Merkies, RA Lewis, RJ Barohn, CL Koski, ...
Journal of the Peripheral Nervous System 15 (4), 326-333, 2010
1482010
Nerve conduction studies in Charcot‐Marie‐Tooth polyneuropathy associated with a segmental duplication of chromosome 17
DA Kaku, GJ Parry, R Malamut, JR Lupski, CA Garcia
Neurology 43 (9), 1806-1806, 1993
1421993
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria
MA Ross, RG Miller, L Berchert, G Parry, RJ Barohn, C Armon, WW Bryan, ...
Neurology 50 (3), 768-772, 1998
1401998
Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis
GJ Parry, CMP Rodrigues, MM Aranha, SJ Hilbert, C Davey, P Kelkar, ...
Clinical neuropharmacology 33 (1), 17-21, 2010
1372010
The system can't perform the operation now. Try again later.
Articles 1–20